CSO Dr. Changyun Hu presented data for an FIC anti-A2AR molecule at Adenosine-pathway targeted Cancer Immunotherapy Summit on Jun 22, 2023 with the title:
Targeting Adenosine Pathway With Antagonizing Anti-A2A Antibody to Enhance Anti-Tumor Immunity 
• Discuss current molecules targeting adenosine receptors in preclinic and clinics
• Show the discovery of an antagonizing anti-A2aR antibody to enhance anti-tumor 

immunity

https://adenosine-pathway-immunotherapy.com/